Results 161 to 170 of about 3,495,162 (348)
Metagenomic and biogenic amine changes in cassava fermentation for tucupi production using Pediococcus acidilactici starter culture
Journal of the Science of Food and Agriculture, EarlyView.Abstract BACKGROUND
The use of starter cultures is essential for producing fermented foods with desirable standardized characteristics and for preventing pathogens. Pediococcus acidilactici, isolated from cocoa fermentation, was used in the production of tucupi, a widely appreciated sauce made from the juice of cassava root (manipueira) in the ...Danielle Gama Brício, Maria Beatriz A Gloria, José Augusto Pires Bitencourt, Leandro Araujo Argôlo, Rafaela de Lima Ribeiro, Ilzane Abreu da Silva, Rosinelson da Silva Pena, Alessandra Santos Lopes, Gilson CA Chagas Junior, Nelson Rosa Ferreira +9 morewiley +1 more sourceComprehensive Management of HIV With Multiple Opportunistic Infections: A Case Report. [PDF]
Clin Case RepBoozhmehrani MJ, Hoseinnejad A, Lesani S, Afzalzadeh S, YousefiFard A, Rezaei-Matehkolaei A, Maraghi S, Tavalla M, Taghizadeh Armaki M, Jafarzadeh J, Bastani MN. +10 moreeuropepmc +1 more sourceLower Plasma Antioxidant Defense and Heat Shock Proteins Mark Intra‐Amniotic Sludge Ultrasound Finding
Journal of Ultrasound in Medicine, EarlyView.Objectives
Intra‐amniotic sludge is an independent risk factor for preterm birth. It consists of a biophysical sonographic finding in the amniotic fluid, formed by dense echogenic particles near the cervical internal orifice, due to sterile or infectious inflammatory processes.Clarissa Chavez Ortiz Roberto, Lílian Corrêa Costa‐Beber, Lucas Machado Sulzbacher, Jaíne Borges dos Santos, Anna Karolina Kretschmann Florencio de Souza Bagetti, Eduardo Becker Jr, Matias Nunes Frizzo, Thiago Gomes Heck, Mirna Stela Ludwig +8 morewiley +1 more sourceDefining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
Clinical Infectious Diseases, 2002 S. Aşçıoğlu, J. Rex, B. Pauw, J. Bennett, J. Billé, F. Crokaert, D. Denning, J. Donnelly, J. Edwards, Z. Erjavec, D. Fiére, O. Lortholary, J. Maertens, J. Meis, T. Patterson, J. Ritter, D. Selleslag, P. Shah, D. Stevens, T. Walsh +19 moresemanticscholar +1 more sourceSafety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials
JEADV Clinical Practice, EarlyView.ABSTRACT Background
Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.Antonio Costanzo, Antonio Torrelo, Eric L. Simpson, Marjolein De Bruin‐Weller, Diamant Thaçi, Norito Katoh, Silvia Sabatino, Andrew Buchanan, Kasia Morawska, Samuel Ogwu, Karen Denning, Jonathan I. Silverberg +11 morewiley +1 more sourceOccurrence of Severe Opportunistic Infections in Children Living with HIV Under Regular Follow-Up in Lubumbashi: Associated Factors and Clinical Implications
Astrid, Lokotshe Kanyama, Bijou, Kanku Kazibale, Nathalie, Mbuyamba Mutombo, Jirene, Ndjibu Ebondo, Panshi, Odon Panshi wa, Lukamba, Jerome Nyembo, Dodo, Manda Mukendi, Franck, Kasans Tshinyengo, Emmanuel, Tshibangu Manyonga, Eric, Kasamba Ilunga, Mick, Shongo ya Pongombo, Philomène, Lungu Anzwal +11 moreopenalex +1 more source
